Journament

Keyword Connections - remission Keywords

Connection Type	Connection
Journals	Journal of affective disorders The Cochrane database of systematic reviews arthritis & rheumatology (hoboken, nj) pediatric nephrology (berlin, germany) aids and behavior Ocular immunology and inflammation cns drugs Journal of health economics and outcomes research
Research Groups	No Research Group Connected
Bibliographies	[1] Predictors of cognitive remediation therapy improvement in (partially) remitted unipolar depression. [2] Pharmacological interventions for treatment-resistant depression in adults. [3] Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? [4] Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop. [5] "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. [6] Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial. [7] Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus. [8] clinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents [9] antipsychotic treatments; focus on lurasidone [10] addiction and choice: theory and new data [11] efficacy of curcumin as adjuvant therapy to induce or maintain remission in ulcerative colitis patients: an evidence-based clinical review [12] physical rehabilitation of patients with amputation stump of thigh because of trauma [13] Validation of a Model Estimating the Budget Impact of Video Capsule Endoscopy for Surveillance of Crohn's Disease in an Italian Center. [14] Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. [15] The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis [16] Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis [17] HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation. [18] TDAH: remissão na adolescência e preditores de persistência em adultos ADHD: Remission in adolescence and predictors of persistence into adulthood [19] ADHD remission, inclusive special education, and socioeconomic disparities [20] Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission [21] Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study. [22] Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis [23] Identification of targetable BRAF ΔN486_P490 variant by whole genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma. [24] Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam. [25] Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly. [26] Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial. [27] Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss. [28] "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. [29] Type 2 Diabetes Mellitus (T2DM) “Remission” in Non-bariatric Patients 65 Years and Older [30] Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial. [31] Association of CD204 macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT. [32] New Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range". [33] Parallel but connected: Nuances of conducting behavioral and social science research alongside ethically challenging HIV remission trials [34] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis [35] Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1 [36] Certolizumab pegol for induction of remission in Crohn's disease [37] Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis [38] Calorie restriction for long-term remission of type 2 diabetes [39] Remission and withdrawal of therapy in lupus nephritis [40] Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis [41] Enteral nutritional therapy for induction of remission in Crohn's disease [42] Vedolizumab for induction and maintenance of remission in ulcerative colitis [43] Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis [44] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis [45] Immune reconstitution therapies: concepts for durable remission in multiple sclerosis [46] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis [47] [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission] [48] Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991 [49] Report by the ACNP Task Force on response and remission in major depressive disorder [50] Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial [51] Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone [52] Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial [53] Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder [54] correlation of endoscopic findings of gastric mucosa-associated lymphoid tissue lymphoma with recurrence after complete remission [55] response to: remission of hidradenitis suppurativa after bariatric surgery [56] hypopigmented mycosis fungoides: clinical, histological, and immunohistochemical remission induced by narrow-band ultraviolet b [57] prolonged remission of pemphigus induced by dexamethasone-cyclophosphamide pulse therapy [58] complete remission of nephrotic syndrome and acute kidney injury in crescentic iga nephropathy: role of mycophenolate sodium [59] comparison of direct immunofluorescence of plucked hair and skin for evaluation of immunological remission in pemphigus [60] primary cutaneous anaplastic large-cell lymphoma: complete remission for 13 years after denileukin diftitox [61] sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study [62] fibromyalgia syndrome: a case report on controlled remission of symptoms by a dietary strategy [63] roux-en y gastric bypass results in long-term remission of hepatocyte apoptosis and hepatic histological features of non-alcoholic steatohepatitis [64] unanticipated rapid remission of refractory bulimia nervosa, during high-dose repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex: a case report [65] long-term remission of primary bone marrow diffuse large b-cell lymphoma treated with high-dose chemotherapy rescued by in vivo rituximab-purged autologous stem cells [66] tumour lysis syndrome and partial remission occurring after administration of a test dose of obinutuzumab [67] sustained remission in a case of lupus nephritis with cyclosporin therapy [68] efficacy of curcumin as adjuvant therapy to induce or maintain remission in ulcerative colitis patients: an evidence-based clinical review [69] complete psa remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection [70] maintaining remission in distal ulcerative colitis and ulcerative proctitis [71] complete remission of nephrotic syndrome of hepatitis b virus-associated membranous glomerulopathy after lamivudine monotherapy [72] impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma [73] The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease. [74] Deep remission in inflammatory bowel disease: looking beyond symptoms [75] Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab [76] Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease [77] Adalimumab induces deep remission in patients with Crohn's disease [78] Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease [79] Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis [80] Unconventional success: Achieving long-term remission with pembrolizumab in recurrent high-grade endometrial carcinosarcoma.